ProfileGDS5822 / ILMN_2425032
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 77% 84% 80% 80% 83% 82% 80% 81% 80% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1100.677
GSM1276600PDAC Late Ablation Control 2222.784
GSM1276601PDAC Late Ablation Control 3190.780
GSM1276602PDAC Late Ablation 1137.480
GSM1276603PDAC Late Ablation 221683
GSM1276604PDAC Late Ablation 3190.482
GSM1303940PDAC Late Ablation_anti-CTLA4 1135.480
GSM1303941PDAC Late Ablation_anti-CTLA4 2207.581
GSM1303942PDAC Late Ablation_anti-CTLA4 3194.380